Journal Impact Factor
×

Journal Finder App

QR Code

Scan QR code to Download

Download App

Frontiers in Clinical Drug Research - Anti Allergy Agents Impact factor 2025


The latest impact factor of Frontiers in Clinical Drug Research - Anti Allergy Agents and all the other Web of Science journals was released on 20th June 2025 by Clarivate. Through this web page, researchers can check the impact factor, total citation, journal quartile, and journal aim & scope.

Frontiers in Clinical Drug Research - Anti Allergy Agents: Aim & Scope

Frontiers in Clinical Drug Research - Anti Allergy Agents is a Web of Science indexed journal tha publishes research in the area: Drug Discovery (Q4); Immunology and Allergy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4).
The ISSN of this journal is 22146938, 24523194.

Impact factor of Frontiers in Clinical Drug Research - Anti Allergy Agents

Journal Title Frontiers in Clinical Drug Research - Anti Allergy Agents
Impact Factor
SJR 0.105
ISSN 22146938, 24523194
Quartile Q4

The Journal Impact Factor is defined as citations to the journal in the JCR year to items published in the previous two years, divided by the total number of scholarly items, also known as citable items, (these comprise articles and reviews) published in the journal in the previous two years.

Impact factor data has a strong influence on the scientific community, affecting decisions on where to publish, whom to promote or hire, the success of grant applications, and even salary bonuses.

Only journals listed in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI) receive an Impact Factor.


Similiar journals to publish


Frontiers in Clinical Drug Research - Anti Allergy Agents
ISSN: 22146938, 24523194
Journal Impact:
Journal Scope: Drug Discovery (Q4); Immunology and Allergy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
ISSN: 1875614X
Journal Impact:
Journal Scope: Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)

Frontiers in Clinical Drug Research - Anti Infectives
ISSN: 24523208, 23523212
Journal Impact:
Journal Scope: Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)

Anti-Cancer Agents in Medicinal Chemistry
ISSN: 18755992
Journal Impact: 2.6
Journal Scope: Oncology | Chemistry, Medicinal

Anti-Infective Agents
ISSN: 22113533, 22113525
Journal Impact:
Journal Scope: Infectious Diseases (Q4); Pharmacology (Q4)

Frontiers in Anti-infective Drug Discovery
ISSN: 1879663X, 24519162
Journal Impact:
Journal Scope: Drug Discovery (Q4); Infectious Diseases (Q4); Molecular Medicine (Q4)

Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
ISSN: 1710-1492
Journal Impact:
Journal Scope:

Allergy: European Journal of Allergy and Clinical Immunology
ISSN: 13989995
Journal Impact:
Journal Scope: Immunology (Q1); Immunology and Allergy (Q1)

Recent Patents on Anti-Cancer Drug Discovery
ISSN: 22123970
Journal Impact: 2.5
Journal Scope: Oncology | Pharmacology & Pharmacy

Recent Advances in Anti-Infective Drug Discovery
ISSN: 27724352
Journal Impact:
Journal Scope: Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (medical) (Q3)



About SCI

SCI is a multidisciplinary citation index. Science Citation Index covers 9,000+ journals across 177 scientific disciplines. SCI was established in 1900 to the current. SCI-indexed journals are indexed by SCI and SSCI. SCI is described as the world's leading journal.

All journals covered in this database are reviewed for sufficiently high quality each year.


How to publish in SCI journals?

  1. Identify an SCI indexed Journal.
  2. Compose Your Research Paper As Per The Guidelines Of The Journal.
  3. Visit the journal's website to submit your research paper.
  4. Notification Of Acceptance From The Publisher.
  5. Confirmation Of Your Paper Being Published


Journals